Kingdon Capital Management, L.L.C. Merck & Co., Inc. Call Options Transaction History

Kingdon Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $17.1 Million - $19.5 Million	-243,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $15.4 Million - $21.4 Million	243,500 New	243,500 $18.7 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $20.3 Million - $23.9 Million	-400,200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $20.4 Million - $23.7 Million	400,200 New	400,200 $21.8 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.